CMS-121

N/A

Report date: 2024/11/29 20:00:39
NME

Base Information

Drug NameCMS-121
Drug Alias NameCMS-121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFatty acid synthase inhibitors
TargetsFatty acid synthase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSalk Institute
China Registration ClassN/A

Develop Information

Active CompaniesVirogenics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A